M1 Kliniken AG (XTER:M12) EBIT : €14.2 Mil (TTM As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

What is M1 Kliniken AG EBIT?

M1 Kliniken AG's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2023 was €7.5 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was €14.2 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. M1 Kliniken AG's annualized ROC % for the quarter that ended in Jun. 2023 was 7.02%. M1 Kliniken AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 36.75%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. M1 Kliniken AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 4.48%.

M1 Kliniken AG EBIT Historical Data

The historical data trend for M1 Kliniken AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

M1 Kliniken AG EBIT Chart

M1 Kliniken AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

8.10

13.09

9.50

15.34

11.06

M1 Kliniken AG Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EBIT	Get a 7-Day Free Trial												8.51	6.83	4.38	6.68	7.49

Competitive Comparison of M1 Kliniken AG's EBIT

For the Medical Care Facilities subindustry, M1 Kliniken AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

M1 Kliniken AG's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, M1 Kliniken AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where M1 Kliniken AG's EV-to-EBIT falls into.

M1 Kliniken AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €14.2 Mil.

M1 Kliniken AG (XTER:M12) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

M1 Kliniken AG's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2022 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	14.558 * ( 1 - 40.7% )	/	( (123.288	+	122.504)	/ 2 )
=	8.632894	/	122.896
=	7.02 %

where

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	197.025	-	21.894	-	( 51.843	-	max(0, 37.466	-	107.307	+	51.843	))
=	123.288

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	203.232	-	31.708	-	( 49.02	-	max(0, 42.193	-	115.289	+	49.02	))
=	122.504

Note: The Operating Income data used here is two times the semi-annual (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

M1 Kliniken AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2022		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	14.988	/	( ( (17.178 + max(20.618, 0))	+	(15.439 + max(28.336, 0)) )	/	2 )
=	14.988	/	( ( 37.796	+	43.775 )	/	2 )
=	14.988	/	40.7855
=	36.75 %

where Working Capital is:

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(21.773	+	26.908	+	6.026)	-	(21.894	+	0	+	12.195)
=	20.618

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(33.243	+	26.87	+	6.156)	-	(31.708	+	0	+	6.225)
=	28.336

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

M1 Kliniken AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	14.175	/	316.656
	=	4.48 %

M1 Kliniken AG EBIT Related Terms

Thank you for viewing the detailed overview of M1 Kliniken AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

M1 Kliniken AG (XTER:M12) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » M1 Kliniken AG (XTER:M12) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

M12:Germany M12:Germany M12:Germany

Address

Grunauer strasse 5, Berlin, BB, DEU, 12557

Website

https://www.m1-kliniken.de

M1 Kliniken AG is a healthcare company operating in the market for aesthetic medical treatment and plastic surgery. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. Majority of its revenue derived from Trade segment.

Executives

Kilian Brenske	Board of Directors
Attila Strauss	Board of Directors

M1 Kliniken AG (XTER:M12) Headlines

No Headlines